PF-Atlas › Clinical Trials › NCT06677879
A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.
Proton radiotherapy · Phase 2
Registry ID
NCT06677879
Phase
Phase 2
Status
Recruiting
Drug / intervention
Proton radiotherapy
Sponsor
Shanghai Proton and Heavy Ion Center
Start
2024-08-01
Enrollment
780
Locations
1
About this trial
The goal of this study is to investigate the differences in toxicity and efficacy between proton and photon hypofractionated radiotherapy following lumpectomy or mastectomy for breast cancer. The main questions it aims to answer are: 1. What is the difference in the incidence of radiation-related grade 2 or higher adverse events within two years following proton versus photon therapy after breast-conserving surgery? 2. What is the difference in the incidence of radiation-related grade 2 or higher adverse events within two years following proton versus photon therapy after mastectomy?
Explore related
Medical disclaimer. This page summarizes public trial data for NCT06677879 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.